XBiotech Inc.XBITNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank69
3Y CAGR+5.9%
5Y CAGR-16.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+5.9%/yr
vs +4.6%/yr prior
5Y CAGR
-16.3%/yr
Recent acceleration
Acceleration
+1.3pp
Accelerating
Percentile
P69
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$7.49M+58.9%
2024$4.71M+1.1%
2023$4.66M-26.1%
2022$6.30M-32.8%
2021$9.39M-48.4%
2020$18.20M+280.6%
2019$4.78M-9.2%
2018$5.27M-31.0%
2017$7.63M-25.7%
2016$10.28M-